Roles for NF-κB in nerve cell survival, plasticity, and disease | Cell Death & Differentiation
NF-κB signaling in inflammation | Signal Transduction and Targeted Therapy
Nuclear Factor κB Signaling in Atherogenesis | Arteriosclerosis, Thrombosis, and Vascular Biology
Frontiers | Interplay Between Non-Canonical NF-κB Signaling and Hepatitis B Virus Infection
NF-κB in the crosshairs: Rethinking an old riddle - ScienceDirect
PDF) Inhibition of Nuclear Factor Kappa B (NF-B):: An Emerging Theme in Anti-Inflammatory Therapies
Frontiers | Nuclear Factor κB (NF-κB)–Mediated Inflammation in Multiple Sclerosis
The complexity of NF-κB signaling in inflammation and cancer | Molecular Cancer | Full Text
Frontiers | NF-κB Pathway as a Potential Target for Treatment of Critical Stage COVID-19 Patients
Mitigation of ALS Pathology by Neuron-Specific Inhibition of Nuclear Factor Kappa B Signaling | Journal of Neuroscience
Inhibitors of NF-κB signaling: 785 and counting | Oncogene
NF-κB - Wikipedia
Multiple Facets of NF-κB in the Heart | Circulation Research
What is NF-κB pathway? | MBInfo
NF-κB as potential target in the treatment of melanoma | Journal of Translational Medicine | Full Text
Curcumin Blocks Cytokine-Mediated NF-κB Activation and Proinflammatory Gene Expression by Inhibiting Inhibitory Factor I-κB Kinase Activity | The Journal of Immunology
What is NF-κB pathway? | MBInfo
NF-κB activation as a pathological mechanism of septic shock and inflammation | American Journal of Physiology-Lung Cellular and Molecular Physiology
Nuclear factor‐kappa β as a therapeutic target for Alzheimer's disease - Jha - 2019 - Journal of Neurochemistry - Wiley Online Library
NF-κB inhibitors in treatment and prevention of lung cancer - ScienceDirect
NF-kB inhibitors and activators | Abcam
NF-κB inhibitors in treatment and prevention of lung cancer - ScienceDirect
Frontiers | Plant polyphenols as inhibitors of NF-κB induced cytokine production—a potential anti-inflammatory treatment for Alzheimer's disease?
NF-κB signaling, liver disease and hepatoprotective agents | Oncogene
